tiprankstipranks
Advertisement
Advertisement
Grail falls -18.4%
PremiumThe FlyGrail falls -18.4%
20d ago
Grail presents ‘positive’ performance, safety results from Pathfinder 2 study
Premium
The Fly
Grail presents ‘positive’ performance, safety results from Pathfinder 2 study
21d ago
Grail reports results from NHS-Galleri trial in presentation at ASCO meeting
Premium
The Fly
Grail reports results from NHS-Galleri trial in presentation at ASCO meeting
21d ago
Daniel Brennan Reiterates Buy on Strong Galleri Momentum, Clinical Catalysts, and Raises Price Target to $69
PremiumRatingsDaniel Brennan Reiterates Buy on Strong Galleri Momentum, Clinical Catalysts, and Raises Price Target to $69
2M ago
Grail reports Q1 EPS ($2.29), consensus ($1.96)
Premium
The Fly
Grail reports Q1 EPS ($2.29), consensus ($1.96)
2M ago
Grail initiated with a Neutral at Mizuho
Premium
The Fly
Grail initiated with a Neutral at Mizuho
2M ago
Block upgraded, Starbucks downgraded: Wall Street’s top analyst calls
PremiumThe FlyBlock upgraded, Starbucks downgraded: Wall Street’s top analyst calls
3M ago
Video: Constellation rises as Citi gets more constructive
Premium
The Fly
Video: Constellation rises as Citi gets more constructive
3M ago
Grail upgraded to Buy from Hold at TD Cowen
Premium
The Fly
Grail upgraded to Buy from Hold at TD Cowen
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100